Skip to main content

Table 3 Codon distribution and calculated genetic barrier at 27 integrase inhibitor susceptible positions in HIV-1 INI-naïve patients

From: HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients

IN codon position

Substitution

Wild type codon

Codon % distribution

Mutational resistance codon

Lower score

IN codon position

Substitution

Wild type codon

Codon % distribution

Mutational resistance codon

Lower scores

   

HAART-naïve (n = 41)

RTI/PI-experienced (n = 54)

     

HAART-naïve (n = 41)

RTI/PI-experienced (n = 54)

  

51

H51Y

CAT

98

100

TAT

1

143

Y143C

TAC

90

90

TGC

1

  

CAC

2

0

TAC

1

  

TAT

10

10

TGT

1

66

T66I

ACA

98

94

ATA

1

 

Y143R

TAC

90

90

CGC

2

  

ACC

0

6

ATC

1

  

TAT

10

10

CGT

2

  

ACG

2

0

ATA

2

146

Q146P

CAA

98

98

CCG

2.5

72

V72I

GTT

32

31

ATT

1

  

CAG

2

2

CCA

2.5

  

GTC

15

6

ATC

1

 

Q146K

CAA

98

98

AAA

2.5

  

GTA

0

6

ATA

1

  

CAG

2

2

AAG

2.5

  

GTG

0

4

ATA

2

147

S147G

AGT

76

70

GGT

1

 

I72

ATT

41

45

 

0

  

AGC

24

30

GGC

2

  

ATC

12

2

 

0

148

Q148H

CAA

80

96

CAT/C

2.5

  

ATA

0

4

 

0

  

CAG

20

4

CAT/C

2.5

 

D72

GAT

0

2

ATT

3.5

 

Q148K

CAA

80

96

AAA

2.5

74

L74I

CTG

72

78

ATA

3.5

  

CAG

20

4

AAG

2.5

  

CTA

10

15

ATA

2.5

 

Q148R

CAA

80

96

CGA

1

  

TTA

10

2

ATA

2.5

  

CAG

20

4

CGG

1

  

TTG

2

0

ATA

3.5

151

V151I

GTA

71

72

ATA

1

 

I74

ATT

0

0

 

0

  

GTG

29

28

ATA

2

  

ATA

2

7

 

0

153

S153Y

TCT

76

87

TAT

2.5

 

M74

ATG

2

0

ATA

1

  

TCC

15

11

TAC

2.5

92

E92Q

GAA

63

61

CAA

2.5

  

TCA

7

2

TAT/C

5

  

GAG

37

39

CAG

2.5

 

A153

GCC

2

0

TAC

5

95

Q95K

CAA

32

28

AAA

2.5

155

N155H

AAT

90

93

CAT

2.5

  

CAG

68

70

AAG

2.5

  

AAC

10

7

CAC

2.5

 

R95

CGG

0

2

AAG

3.5

 

N155S

AAT

90

93

AGT

1

97

T97A

ACA

98

96

GCA

1

  

AAC

10

7

AGC

1

 

A97

GCA

0

4

 

0

157

E157Q

GAA

88

91

CAA

2.5

 

S97

TCA

2

0

GCA

2.5

  

GAG

7

7

CAG

2.5

121

F121Y

TTC

90

98

TAC

2.5

 

Q157

CAA

5

2

 

0

  

TTT

10

2

TAT

2.5

160

K160D

AAA

85

93

GAT/C

3.5

125

T125K

ACA

27

18

AAG

2.5

  

AAG

11

5

GAT/C

3.5

  

ACT

10

4

AAA/G

5

 

R160

AGA

2

0

GAT

4.5

  

ACG

12

24

AAG

2.5

 

Q160

CAA

2

2

GAT/C

5

 

A125

GCA

44

33

AAA

3.5

163

G163R

GGA

63

57

AGA

1

  

GCG

2

6

AAG

3.5

  

GGG

27

39

AGG

1

  

GCT

0

6

AAA/G

6

  

GGT

0

2

CGC,AGA/G

3.5

 

V125

GTG

0

7

AAG

3.5

 

E163

GAA

0

4

AGA

2

  

GTA

2

0

AAA

3.5

 

N163

AAC

0

2

CGC,AGA/G

3.5

 

M125

ATG

2

0

AAG

2.5

 

A163

GCG

0

2

CTG,AGG

3.5

 

P125

CCG

0

2

AAG

5

165

V165I

GTA

56

52

ATA

1

128

A128T

GCA

54

50

ACA

1

  

GTC

22

18

ATC

1

  

GCC

37

46

ACC

1

  

GTT

2

10

ATT

1

  

GCT

9

4

ACT

1

  

GTG

0

2

ATA

2

138

E138K

GAA

100

98

AAA

1

 

I165

ATA

20

18

 

0

 

D138

GAC

0

2

AAA/G

3.5

201

V201I

GTA

24

28

ATA

1

140

G140S

GGA

46

37

AGT/C

3.5

  

GTG

2

2

ATA

2

  

GGC

44

46

AGC

1

 

I201

ATA

74

70

 

0

  

GGT

5

6

AGT

1

203

I203M

ATA

95

98

ATG

1

  

GGG

5

9

AGT/C

3.5

 

M203

ATG

5

2

 

0

 

G140A

GGA

46

37

GCA

2.5

230

S230R

AGC

90

96

AAC

1

  

GGC

44

46

GCC

2.5

 

N230

AAC

10

4

 

0

  

GGT

5

6

GCT

2.5

263

R263K

AGA

85

96

AAA

1

  

GGG

5

6

GCT/G

2.5

  

AGG

15

4

AAG

1

  1. The amino acids differing from wild-type or expected mutant are in boldface.